Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, February 24, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Selkirk Pharma Introduces ClinFAST™ to Expedite Fill/Finish for Clinical Trials
Life Sciences Times
-
February 12, 2025
Pharma
Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic
Life Sciences Times
-
February 11, 2025
Pharma
Alloy Therapeutics Establishes Multi-Year Collaboration with Pfizer to Develop New Antibody Discovery Platform
Life Sciences Times
-
February 11, 2025
Pharma
Osta Therapeutics Strengthens Leadership Team with Two Industry Experts Supporting its Goal of Addressing Antibiotic Resistance
Life Sciences Times
-
January 30, 2025
Pharma
LIB Therapeutics Announces Publication of Phase 3 Study of Lerodalcibep in Homozygous Familial Hypercholesterolemia (HoFH) in Lancet Diabetes & Endocrinology
Life Sciences Times
-
January 27, 2025
Pharma
Results of the First Post-Commercial Utilization Review of JELMYTO® Provide New Evidence that Reinforces its Efficacy and Safety in Patients with Low-Grade Upper Tract...
Life Sciences Times
-
January 11, 2023
0
Pharma
Neurotech Pharmaceuticals, Inc. Expands Executive Team with the Appointment of Scott Hunter as Chief Commercial Officer
Life Sciences Times
-
January 10, 2023
0
Pharma
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon...
Life Sciences Times
-
January 10, 2023
0
Pharma
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603
Life Sciences Times
-
January 9, 2023
0
Pharma
Myrtelle Announces Positive Interim Data in Phase 1/2 Clinical Trial of Its Proprietary Investigational Gene Therapy rAAV-Olig001-ASPA in Canavan Disease
Life Sciences Times
-
January 9, 2023
0
Pharma
Glycomine Announces First Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG
Life Sciences Times
-
January 9, 2023
0
Pharma
Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1
Life Sciences Times
-
January 9, 2023
0
Pharma
FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma
Life Sciences Times
-
January 5, 2023
0
Pharma
PharmaEssentia Establishes a New Research and Development Facility in the Boston Area
Life Sciences Times
-
January 4, 2023
0
Pharma
Biocytogen and Hansoh Pharma Announce an Antibody License Agreement
Life Sciences Times
-
January 3, 2023
0
Pharma
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
Life Sciences Times
-
December 22, 2022
0
Pharma
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes
Life Sciences Times
-
December 21, 2022
0
1
...
12
13
14
...
60
Page 13 of 60
Most Read
BioBuilder Opens New Learning Lab in Allston to Train Future Bio-manufacturing Workforce
February 18, 2025
Nura Bio Expands Leadership Team with C-Suite Appointments
February 18, 2025
XRHealth Acquires Immersive, Digital Therapeutics Company RealizedCare, Creating the Largest AI-Driven Therapeutic XR Platform Globally
February 18, 2025
Pheast Appoints Dr. Raphaël Rousseau as Chief Medical Officer
February 18, 2025